Sinovac has finished the Phrase I and II clinical research stage, involving several hundred volunteers in this age group, which has proved that the vaccine is as safe and efficient.
The Pfizer-BioNTech jab is one of several vaccines bringing hope for an end to the pandemic that has killed more than 1.5 million people worldwide and ravaged economies.
